These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 14728618)

  • 1. Retaking sleeping sickness control in Angola.
    Abel PM; Kiala G; Lôa V; Behrend M; Musolf J; Fleischmann H; Théophile J; Krishna S; Stich A
    Trop Med Int Health; 2004 Jan; 9(1):141-8. PubMed ID: 14728618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The return of sleeping sickness in an epidemic form: international action for drugs].
    Kager PA
    Ned Tijdschr Geneeskd; 2002 Dec; 146(52):2527-30. PubMed ID: 12532663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human African trypanosomiasis.
    Brun R; Blum J; Chappuis F; Burri C
    Lancet; 2010 Jan; 375(9709):148-59. PubMed ID: 19833383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human African trypanosomiasis in Angola: clinical observations, treatment, and use of PCR for stage determination of early stage of the disease.
    Truc P; Lando A; Penchenier L; Vatunga G; Josenando T
    Trans R Soc Trop Med Hyg; 2012 Jan; 106(1):10-4. PubMed ID: 22093811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. African sleeping sickness.
    Hedley L; Fink D; Sparkes D; Chiodini PL
    Br J Hosp Med (Lond); 2016 Oct; 77(10):C157-C160. PubMed ID: 27723399
    [No Abstract]   [Full Text] [Related]  

  • 6. Arsenicals (melarsoprol), pentamidine and suramin in the treatment of human African trypanosomiasis.
    Nok AJ
    Parasitol Res; 2003 May; 90(1):71-9. PubMed ID: 12743807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mortality trends and risk factors in advanced stage-2 Human African Trypanosomiasis: A critical appraisal of 23 years of experience in the Democratic Republic of Congo.
    Kazumba LM; Kaka JT; Ngoyi DM; Tshala-Katumbay D
    PLoS Negl Trop Dis; 2018 Jun; 12(6):e0006504. PubMed ID: 29897919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of human African trypanosomiasis in the Quiçama focus, Angola.
    Ruiz JA; Simarro PP; Josenando T
    Bull World Health Organ; 2002; 80(9):738-45. PubMed ID: 12378293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Killer coma: the evolving story of sleeping sickness treatment.
    Lancet; 2010 Jan; 375(9709):93. PubMed ID: 20109869
    [No Abstract]   [Full Text] [Related]  

  • 10. Control and surveillance of human African trypanosomiasis.
    World Health Organization
    World Health Organ Tech Rep Ser; 2013; (984):1-237. PubMed ID: 24552089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The situation of sleeping sickness in Angola: a calamity.
    Stanghellini A; Josenando T
    Trop Med Int Health; 2001 May; 6(5):330-4. PubMed ID: 11348527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The elimination of Trypanosoma brucei gambiense sleeping sickness in the focus of Luba, Bioko Island, Equatorial Guinea.
    Simarro PP; Franco JR; Ndongo P; Nguema E; Louis FJ; Jannin J
    Trop Med Int Health; 2006 May; 11(5):636-46. PubMed ID: 16640616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of melarsoprol and eflornithine as first-line regimens for gambiense sleeping sickness in nine Médecins Sans Frontières programmes.
    Balasegaram M; Young H; Chappuis F; Priotto G; Raguenaud ME; Checchi F
    Trans R Soc Trop Med Hyg; 2009 Mar; 103(3):280-90. PubMed ID: 18947846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sleep structure: a new diagnostic tool for stage determination in sleeping sickness.
    Buguet A; Bisser S; Josenando T; Chapotot F; Cespuglio R
    Acta Trop; 2005 Jan; 93(1):107-17. PubMed ID: 15589803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eflornithine is safer than melarsoprol for the treatment of second-stage Trypanosoma brucei gambiense human African trypanosomiasis.
    Chappuis F; Udayraj N; Stietenroth K; Meussen A; Bovier PA
    Clin Infect Dis; 2005 Sep; 41(5):748-51. PubMed ID: 16080099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment outcomes and risk factors for relapse in patients with early-stage human African trypanosomiasis (HAT) in the Republic of the Congo.
    Balasegaram M; Harris S; Checchi F; Hamel C; Karunakara U
    Bull World Health Organ; 2006 Oct; 84(10):777-82. PubMed ID: 17128357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gambian trypanosomiasis and synergism between melarsoprol and eflornithine: first case report.
    Simarro PP; Asumu PN
    Trans R Soc Trop Med Hyg; 1996; 90(3):315. PubMed ID: 8758090
    [No Abstract]   [Full Text] [Related]  

  • 18. A literature review of economic evaluations for a neglected tropical disease: human African trypanosomiasis ("sleeping sickness").
    Sutherland CS; Yukich J; Goeree R; Tediosi F
    PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003397. PubMed ID: 25654605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy for second-stage human African trypanosomiasis.
    Lutje V; Seixas J; Kennedy A
    Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD006201. PubMed ID: 23807762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-sleeping sickness drugs and cancer chemotherapy.
    Barrett SV; Barrett MP
    Parasitol Today; 2000 Jan; 16(1):7-9. PubMed ID: 10637579
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.